These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8649442)

  • 1. A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL.
    Jost CR; Titus JA; Kurucz I; Segal DM
    Mol Immunol; 1996 Feb; 33(2):211-9. PubMed ID: 8649442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria.
    Kurucz I; Titus JA; Jost CR; Jacobus CM; Segal DM
    J Immunol; 1995 May; 154(9):4576-82. PubMed ID: 7536774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule.
    George AJ; Titus JA; Jost CR; Kurucz I; Perez P; Andrew SM; Nicholls PJ; Huston JS; Segal DM
    J Immunol; 1994 Feb; 152(4):1802-11. PubMed ID: 8120389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian expression and secretion of functional single-chain Fv molecules.
    Jost CR; Kurucz I; Jacobus CM; Titus JA; George AJ; Segal DM
    J Biol Chem; 1994 Oct; 269(42):26267-73. PubMed ID: 7929344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
    Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
    Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient tumor cell lysis mediated by a bispecific single chain antibody expressed in Escherichia coli.
    Gruber M; Schodin BA; Wilson ER; Kranz DM
    J Immunol; 1994 Jun; 152(11):5368-74. PubMed ID: 8189055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical applications of single-chain antibodies.
    Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
    Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection for Anti-transferrin Receptor Bispecific T-cell Engager in Different Molecular Formats.
    Fu MP; Guo ZL; Tang HL; Zhu HF; Shen GX; He Y; Lei P
    Curr Med Sci; 2020 Feb; 40(1):28-34. PubMed ID: 32166662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
    Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
    J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells.
    Kipriyanov SM; Moldenhauer G; Strauss G; Little M
    Int J Cancer; 1998 Aug; 77(5):763-72. PubMed ID: 9688311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-chain mono- and bispecific antibody derivatives with novel biological properties and antitumour activity from a COS cell transient expression system.
    Hayden MS; Linsley PS; Gayle MA; Bajorath J; Brady WA; Norris NA; Fell HP; Ledbetter JA; Gilliland LK
    Ther Immunol; 1994 Jan; 1(1):3-15. PubMed ID: 7584477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
    Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
    Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody.
    Holliger P; Brissinck J; Williams RL; Thielemans K; Winter G
    Protein Eng; 1996 Mar; 9(3):299-305. PubMed ID: 8736497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functions.
    Helfrich W; Haisma HJ; Magdolen V; Luther T; Bom VJ; Westra J; van der Hoeven R; Kroesen BJ; Molema G; de Leij L
    J Immunol Methods; 2000 Apr; 237(1-2):131-45. PubMed ID: 10725458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
    Guettinger Y; Barbin K; Peipp M; Bruenke J; Dechant M; Horner H; Thierschmidt D; Valerius T; Repp R; Fey GH; Stockmeyer B
    J Immunol; 2010 Feb; 184(3):1210-7. PubMed ID: 20042573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fab-scFv fusion protein: an efficient approach to production of bispecific antibody fragments.
    Lu D; Jimenez X; Zhang H; Bohlen P; Witte L; Zhu Z
    J Immunol Methods; 2002 Sep; 267(2):213-26. PubMed ID: 12165442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single-chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor.
    Vallera DA; Panoskaltsis-Mortari A; Jost C; Ramakrishnan S; Eide CR; Kreitman RJ; Nicholls PJ; Pennell C; Blazar BR
    Blood; 1996 Sep; 88(6):2342-53. PubMed ID: 8822957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins.
    Goyal A; Batra JK
    Biochem J; 2000 Jan; 345 Pt 2(Pt 2):247-54. PubMed ID: 10620501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
    McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
    Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of T lymphocytes to melanoma cells through chimeric anti-GD3 immunoglobulin T-cell receptors.
    Yun CO; Nolan KF; Beecham EJ; Reisfeld RA; Junghans RP
    Neoplasia; 2000; 2(5):449-59. PubMed ID: 11191112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.